Chemours continues its focus on promoting sustainable innovation in hydrogen production through water electrolysis
WILMINGTON, Del., May 11, 2022-(BUSINESS WIRE)-The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, is now announced its participation in a fundraiser for Wilmington, Delaware-based Versogen Inc., a leader in developing anion exchange membrane (AEM) technology for use in hydrogen production. Founded by University of Delaware professor Yushan Yan, Versogen’s AEM technology offers a reliable and affordable way to produce green hydrogen on scale.
Green hydrogen is the most promising alternative fuel to reduce greenhouse gas emissions in transportation and other industries that rely primarily on fossil fuels. When made through water electrolysis and powered by renewable energy, a lot of green hydrogen can be produced while producing zero emissions. This process is essential to clean energy transfer and meet global decarbonization goals.
“Chemours is enthusiastic about the economic potential of hydrogen and our role in it, and we are constantly looking for opportunities to accelerate innovation and new technologies for clean energy,” said Denise Dignam, President, Advanced Performance Materials for Chemours. “We are excited to participate with Versogen to help strengthen their ongoing scale-up and have the opportunity to work with a start-up in our backyard to better understand the synergy between AEM technology and our Nafion ™ ion exchange membranes in green hydrogen. production. “
As part of Chemours ’commitment to innovative and responsible chemistry that enables the sustainable products of the future, we work across the entire value chain to deliver advanced solutions that solve some of our customers and partner’s biggest challenges. As part of those efforts, Chemours is also a steering member of the Hydrogen Council and has joined Hydrogen Europe and the European Clean Hydrogen Alliance to help realize the potential role of hydrogen in global energy transfer.
About The Chemours Company
Chemours Company (NYSE: CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market -specific products, application expertise and chemistry -based innovations. We deliver customized solutions with a wide range of industrial and specialty chemical products for the markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industry, and oil and gas. Our flagship products include well-known brands such as Ti-Pure, Opteon, Freon ™, Teflon ™, Viton, Nafion ™, and Krytox ™. The company has approximately 6,400 employees and 29 manufacturing sites serving approximately 3,200 customers in approximately 120 countries. Chemours is headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC.
For more information, we invite you to visit chemours.com or follow us on Twitter @Chemours or LinkedIn.
Dependent Statements
This press release contains future statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, relating to risks and uncertainties. Future statements provide current expectations of future events based on certain assumptions and include any statements that are not directly related to a historical or current fact. The words “believe,” “hope,” “hopeful,” “wait,” “plan,” “estimate,” “target,” “project” and similar expressions, among others, commonly refer to ” future statements, “to speak only on the date when such statements were made. These statements may respond, among other things, to the outcome or resolution of any pending or future environmental liabilities, the initiation, outcome or resolution of any regulatory inquiry, investigation or continuation, initiation, outcome or settling any litigation, changes in U.S. environmental regulations or other jurisdictions that affect the need for or adoption of our products, expected future operational and financial performance for our segments. individually and with our company as a whole, business plans, prospects, targets, objectives and commitments, capital investments and projects and target capital expenditures, plans for dividends or repurchases part, adequate or longevity of intellectual property protection, cost reductions or savings targets, plans to increase kaka profitability and growth, our ability to make acquisitions, incorporate acquired businesses or assets into our operations, and achieve the expected synergy or cost savings, all of which are subject to significant risks and uncertainties that can cause actual results that differ materially from those expressed or implied by such statements. Future statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Future statements also include risks and uncertainties beyond Chemours ’control. In addition, the current COVID-19 pandemic has had a major impact on the national and global economy and commodity and financial markets, which we have had and expect to continue to have a negative impact on our financial results. The full extent and impact of the pandemic is still being determined and to date has included significant volatility in the financial and commodity markets and a severe disruption in economic activity. The public and private sector response has led to travel restrictions, temporary business closures, quarantines, stock market volatility, and delays in consumer and commercial activity around the world. Matters outside our control have affected our business and operations and may or may continue to impede our ability to provide products and services to customers, cause disruption to our supply chains, adversely affect our business partners, significantly reduce the demand for our products, adverse health and welfare of our staff or cause other unforeseen circumstances. Additionally, there may be other risks and uncertainties that Chemours cannot determine at this time or that Chemours does not currently expect to have a material impact on its business. Factors that may cause or contribute to these discrepancies include risks, uncertainties and other factors discussed in our submissions to the U.S. Securities and Exchange Commission, including our Quarterly Report on Form 10- Q for the quarter ended March 31, 2022 and in our Annual Report on Form 10-K for the year ended December 31, 2021. Chemours has no obligation to amend or update any future statements for any reason , unless required by law.
Check out the source version at businesswire.com: https://www.businesswire.com/news/home/20220511005997/en/
Contacts
Investors
Jonathan Lock
SVP, Chief Development Officer
+1.302.773.2263
[email protected]
Kurt Bonner
ManagerInvestor Relations
+1.302.773.0026
[email protected]
NEWS MEDIA
Cassie Olszewski
Media Relations and Financial Communications Manager
+1.302.219.7140
[email protected]